familial hemolytic anemiaResearch
Recent research highlights the potential of pyruvate kinase activators in treating hereditary hemolytic anemias. The study reviews current evidence and discusses the clinical implications of these activators for patient care.
pyruvate kinase activators in hereditary haemolytic anaemias current evidence and clinical potential
Original title: “Pyruvate kinase activators in hereditary haemolytic anaemias: current evidence and clinical potential.”